Results 241 to 250 of about 1,000,365 (329)

Youth Perspectives of School-Based Health Education: Findings from a US Youth-Led Nationwide Qualitative Survey. [PDF]

open access: yesHealth Educ J
Durden A   +15 more
europepmc   +1 more source

Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background and Aims Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population ...
Oumarou Nabi   +10 more
wiley   +1 more source

Impact of Electronic Nicotine Delivery Systems on Oral Mucosa: A Cytopathological and Molecular Study

open access: yesJournal of Oral Pathology &Medicine, EarlyView.
ABSTRACT Background The packaging and marketing of electronic cigarettes (e‐cigs) often target younger demographics. This study aimed to evaluate gene expression in e‐cig users through exfoliative cytology. Methods Samples were collected from 17 e‐cig users and 10 nonsmokers as controls.
Alba Pérez‐Jardón   +10 more
wiley   +1 more source

A Retrospective Study of High‐Risk Infants: Insights From a Regional Hospital in Victoria, Australia

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim To determine the magnitude of high‐risk infants cared for at a regional hospital in Victoria, Australia and to identify the resources required to care for them. Methods A retrospective study was conducted between January 2017 and December 2019 in a regional hospital in Victoria, Australia.
Romanie Rodrigo   +4 more
wiley   +1 more source

Associations between childhood risk factors and alcohol treatment outcomes in adolescence. [PDF]

open access: yesAlcohol Alcohol
Komarnyckyj M   +5 more
europepmc   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy